Abstract
There is little epidemiological data on heart failure (HF) in the younger age groups dominating clinical HF trials. We assessed gender-specific long-term HF incidence and mortality in an urban community-based sample of middle-aged subjects. Between 1974 and 1992, 33,342 HF-free subjects (10,900 [32.7%] women, mean age 45.7 ± 7.4 years) were included in the Malmö Preventive Project, on average 21.7 ± 4.3 years before study end. Patients hospitalised for or dying of HF were categorised as HF patients, and 120 (1.1%) women versus 644 (2.9%) men experienced HF: 6.0 vs. 12.3 cases per 10,000 person years; hazard ratio [HR] 0.61, 95% confidence interval [CI] 0.50–0.74, P < 0.0001. Among all subjects, women compared with men had lower all-cause (49.3 vs. 84.0 cases per 10,000 person years; HR 0.68, 95% CI 0.64–0.73, P < 0.0001) and HF-related (2.6 vs. 7.4 cases per 10,000 person years; HR 0.50, 95% CI 0.37–0.67, P < 0.0001) mortality risk. Female and male HF patients had similar age-adjusted mortality risk: 1,314 vs. 1,602 cases per 10,000 patient years; HR 0.78, 95% CI 0.58–1.07, P = 0.12. Among HF patients, 55.3% of deaths in women and 40.6% in men were non-cardiovascular, and only 7.9% deaths were due to HF. In conclusion: In a middle-aged, urban, community-based sample, women had lower risk of HF, all-cause death and HF-related death over two decades of follow-up. Female and male HF patients had similar mortality risk after the diagnosis of HF. In these comparatively young HF patients, few deaths were due to HF and more than 4 out of 10 deaths were non -cardiovascular.
Similar content being viewed by others
References
Schocken DD, Arrietta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 1992;20:301–6.
Petrie MC, Dawson NF, Murdoch DR, Davie AP, McMurray JJV. Failure of women’s hearts. Circulation. 1999;99:2334–41.
Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol. 1993;22:6A–13A.
Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J. 1991;121:951–7. doi:10.1016/0002-8703(91)90225-7.
McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJV, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 1997;350:829–33. doi:10.1016/S0140-6736(97)03033-X.
Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557–62. doi:10.1001/jama.275.20.1557.
Galderisi M, Andersson KM, Wilson PW, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham heart study). Am J Cardiol. 1991;68:85–9. doi:10.1016/0002-9149(91)90716-X.
Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in the Framingham Heart Study. Circulation. 1993;88:107–15.
Simon T, Mary-Krause M, Funck-Brentano C, Jaillon P, on behalf of the CIBIS II Investigators. Sex differences in the prognosis of congestive heart failure, Results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation. 2001;103:375–80.
Lenzen MJ, Rosengren A, Scholte op Reimer WJS, Follath F, Boersma E, Simoons ML, et al. Management of patients with heart failure in clinical practice: differences between men and women. Heart. 2008;94:e10–78. doi:10.1136/hrt.2006.099523.
Jessup M, Pina IL. Is it important to examine gender differences in the epidemiology and outcome of severe heart failure. J Thorac Cardiovasc Surg. 2004;127:1247–52. doi:10.1016/j.jtcvs.2003.09.032.
Cline CM, Willenheimer RB, Erhardt LR, Wiklund I, Israelsson BY. Health-related quality of life in elderly patients with heart failure. Scand Cardiovasc J. 1999;33:278–85. doi:10.1080/14017439950141524.
Strömberg A, Mårtensson J. Gender differences in patients with heart failure. Eur J Cardiovasc Nurs. 2003;2:7–8. doi:10.1016/S1474-5151(03)00002-1.
SOLVD The investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left-ventricular ejection fractions. N Engl J Med. 1992;327:685–91.
CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429–35.
Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and and ventricular enlargement trial. The SAVE investigators. N Engl J Med. 1992;327:669–77.
Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation. 1999;100:2312–8.
Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349–55. doi:10.1056/NEJM199605233342101.
MERIT-HF StudyGroup. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet. 1999;353:2001–7. doi:10.1016/S0140-6736(99)04440-2.
Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651–8. doi:10.1056/NEJM200105313442201.
Packer M, O’Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, et al. Effect of amplodipine on morbidity and mortality in severe heart failure. N Engl J Med. 1996;335:1107–14. doi:10.1056/NEJM199610103351504.
The Digitalis Investigation Group. The effects of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525–33. doi:10.1056/NEJM199702203360801.
Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000;355:1582–7. doi:10.1016/S0140-6736(00)02213-3.
Feinglass J, Martin GJ, Lin E, Johnson MR, Gheorghiade M. Is heart failure survival improving? Evidence from 2323 elderly patients hospitalized between 1989–2000. Am Heart J. 2003;146:111–4. doi:10.1016/S0002-8703(03)00116-9.
Gustafsson F, Torp-Pedersen C, Burchart H, Buch P, Seibaek M, Kjoller E, et al. Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure. Eur Heart J. 2004;25:129–35. doi:10.1016/j.ehj.2003.10.003.
Mejhert M, Holmgren J, Wandell P, Persson H, Edner M. Diagnostic tests, treatment, and follow-up in heart failure patients—is there a gender bias in the coherence to guidelines. Eur J Heart Fail. 1999;1:407–10. doi:10.1016/S1388-9842(99)00053-7.
Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H, et al. Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity. J Intern Med. 2000;247:19–29. doi:10.1046/j.1365-2796.2000.00568.x.
European Society of Cardiology, Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task Force for the diagnosis and treatment of Chronic Heart Failure. Eur Heart J. 2001;22:1527–60. doi:10.1053/euhj.2001.2783.
Tasevska-Dinevska G, Kennedy LM, Anevski D, Nilsson P, Christensson A, Willenheimer R. Gender differences in predictors of heart failure morbidity and mortality in an urban Swedish population: the Malmö preventive project. Open Heart Fail J. 2008;1:1–8. doi:10.2174/1876535100801010001.
Ingelsson E, Arnlov J, Sundstrom J, Lind L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail. 2005;7:787–91. doi:10.1016/j.ejheart.2004.12.007.
Deswal A, Bozkurt B. Comparasion of morbidity in women versus men with heart failure and preserved ejection fraction. Am J Cardiol. 2006;97:1228–31. doi:10.1016/j.amjcard.2005.11.042.
Fraizer CG, Alexander KP, Newby LK, Anderson S, Iverson E, Packer M, et al. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction. A pooled analysis of 5 randomized control trials. J Am Coll Cardiol. 2007;49:1450–8. doi:10.1016/j.jacc.2006.11.041.
Willenheimer R. Statistical significance versus clinical relevance in cardiovascular medicine. Prog Cardiovasc Dis. 2001;44:155–67. doi:10.1053/pcad.2001.29144.
Acknowledgments
We want to express our gratitude to all staff for assistance in this study and all subjects who participated in tis study.
Conflict of Interest
None in relation to the presented work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tasevska-Dinevska, G., Kennedy, L.M.A., Nilsson, P.M. et al. Gender aspects on heart failure incidence and mortality in a middle-aged, urban, community-based population sample: the Malmö preventive project. Eur J Epidemiol 24, 249–257 (2009). https://doi.org/10.1007/s10654-009-9320-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-009-9320-4